Drugs / TY014
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03776786 | Dec 2018 → Jul 2019 | yellow fever | Tysana Pte Ltd | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TY014 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03776786 ↗ |
| Route | Intravenous | “TY014 will be administered once through single IV infusion over 30 minutes.” NCT03776786 ↗ |